Excited to share our two companion papers in Cell Host & Microbe on developing a next-gen pan-ebolavirus immunotherapy. From a human Ebola survivor's blood to an optimized antibody cocktail that can protect nonhuman primates vs. all 3 outbreak-causing ebolaviruses. In <3 years! 1/2

Congrats to @_nyudonna_ , Anna Wec, our collaborators Laura Walker, Felix Rey, Zachary A. Bornholdt, Forsell Lab, other coauthors on our new paper in PNAS: Single-cell dynamics of B cell response in human recipients of the yellow fever virus vaccine. pnas.org/content/early/…

Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies Press release here: dynotx.com/news/press-rel…

Our new paper in Science: A 'Trojan horse' bispecific antibody strategy for broad protection against ebolaviruses. bit.ly/2bXgDeH

Here's a video that explains the concept of what we did. youtu.be/O2Be3SOlMwE

A two-pronged antibody provides a step towards protection from Ebola. Read the research: scim.ag/2coyn1T

News: Antibodies from Ebola survivor protect mice and ferrets against related viruses dlvr.it/P9zmVv #NIH #NIHnews

Fusion loop region of the Ebola virus glycoprotein a promising vaccine target 🎯 cell.com/cell/fulltext/… & cell.com/cell/fulltext/…

Our newest work :D x.com/ChandranLab/st…

Outstanding meeting and a fantastic networking opportunity! It was a pleasure to learn from you all :) x.com/g_d_williams/s…

Thanks! x.com/g_d_williams/s…